Figure 5From: Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approachesFluorescence immunohistochemistry results. Immunofluorescence micrographs, showing the distribution of hexokinase 1 (a1 to a5) and GLUT1 (c1 to c5). Comparison of average fluorescence intensities in hexokinase 1 levels (b) and GLUT 1 expressions (d) among the RO4987655 dose groups.Back to article page